FOR MYELODYSPLASTIC SYNDROMES

search

Sign In / Join

search

close

person Sign In / Create Account

Myelodysplastic Syndromes News

The HealthTree News for Myelodysplastic Syndromes is a place to learn all about Myelodysplastic Syndromes in easy-to-understand language. The site features news articles, patient stories, Myelodysplastic Syndromes basics articles, and clinical trial updates with new content every week.

Innovation in Myelodysplastic Syndromes: Current Treatment and The Future of MDS

Sep. 15, 2023

Innovation in Myelodysplastic Syndromes: Current Treatment and The Future of MDS

Innovation in Myelodysplastic Syndromes: Diagnosis and Initial Therapies

Sep. 14, 2023

Innovation in Myelodysplastic Syndromes: Diagnosis and Initial Therapies

Living Medicine by Dr. Fred Appelbaum: A Book Review

Sep. 13, 2023

Living Medicine by Dr. Fred Appelbaum: A Book Review

HealthTree 2.0 Pillar Three: A Powerful Patient Data Portal

Sep. 11, 2023

HealthTree 2.0 Pillar Three: A Powerful Patient Data Portal

HealthTree 2.0 Pillar Two: Meaningful Patient to Patient Connections

Sep. 08, 2023

HealthTree 2.0 Pillar Two: Meaningful Patient to Patient Connections

HealthTree 2.0 Pillar One: Personalized, Lifetime Support and Education

Sep. 07, 2023

HealthTree 2.0 Pillar One: Personalized, Lifetime Support and Education

Announcing the Launch of HealthTree 2.0 on October 23rd

Sep. 06, 2023

Announcing the Launch of HealthTree 2.0 on October 23rd

Blood Cancer Awareness Month: What To Expect

Sep. 01, 2023

Blood Cancer Awareness Month: What To Expect

What is the difference between MDS and AML?

Aug. 31, 2023

What is the difference between MDS and AML?

Reblozyl Receives FDA Approval As First-Line Treatment Of Anemia In Lower-Risk MDS Patients

Aug. 29, 2023

Reblozyl Receives FDA Approval As First-Line Treatment Of Anemia In Lower-Risk MDS Patients

POSTPONED: Blood Cancer Awareness Month Movement Challenge

Aug. 28, 2023

POSTPONED: Blood Cancer Awareness Month Movement Challenge

What are the different MDS types?

Aug. 22, 2023

What are the different MDS types?

Recent Articles

Treatment related MDS (t-MDS) image

Treatment related MDS (t-MDS)

August 17, 2023

Treatment-related MDS (t-MDS), is a specific type of MDS that occurs as a consequence of previous cancer treatments, such as chemotherapy or radiation therapy.

How long will I live with MDS? image

How long will I live with MDS?

August 01, 2023

Survival statistics provide valuable insight into the general prognosis of a specific cancer type, but they should be interpreted cautiously.

Promising ENHANCE Study For HR-MDS Pulled in Phase 3 image

Promising ENHANCE Study For HR-MDS Pulled in Phase 3

July 28, 2023

Gilead announced they would be discontinuing their Phase 3 ENHANCE study, which was looking at Magrolimab in High-Risk MDS (HR-MDS) patients.

New In MDS

Reblozyl Receives FDA Approval As First-Line Treatment Of Anemia In Lower-Risk MDS Patients image

Reblozyl Receives FDA Approval As First-Line Treatment Of Anemia In Lower-Risk MDS Patients

Sabatolimab in Patients with Very High/High-Risk MDS and AML image

Sabatolimab in Patients with Very High/High-Risk MDS and AML

Omidubicel Granted FDA Approval For Use In Stem Cell Transplants image

Omidubicel Granted FDA Approval For Use In Stem Cell Transplants

Dr. Sekeres - Improving Treatment for Myelodysplastic Syndromes (MDS) image

Dr. Sekeres - Improving Treatment for Myelodysplastic Syndromes (MDS)

Dr. Chandhok - Improving Drug Efficacy for Underserved Populations image

Dr. Chandhok - Improving Drug Efficacy for Underserved Populations

Dr. Tinsley Vance - Improving Patient Treatment Experience image

Dr. Tinsley Vance - Improving Patient Treatment Experience

Load More

Life With MDS

Innovation in Myelodysplastic Syndromes: Current Treatment and The Future of MDS image

Innovation in Myelodysplastic Syndromes: Current Treatment and The Future of MDS

Innovation in Myelodysplastic Syndromes: Diagnosis and Initial Therapies image

Innovation in Myelodysplastic Syndromes: Diagnosis and Initial Therapies

Living Medicine by Dr. Fred Appelbaum: A Book Review image

Living Medicine by Dr. Fred Appelbaum: A Book Review

Blood Cancer Awareness Month: What To Expect image

Blood Cancer Awareness Month: What To Expect

What is the difference between MDS and AML? image

What is the difference between MDS and AML?

POSTPONED: Blood Cancer Awareness Month Movement Challenge image

POSTPONED: Blood Cancer Awareness Month Movement Challenge

Load More

Trending Articles

Reblozyl Receives FDA Approval As First-Line Treatment Of Anemia In Lower-Risk MDS Patients

Reblozyl Receives FDA Approval As First-Line Treatment Of Anemia In Lower-Risk MDS Patients

How long will I live with MDS?

How long will I live with MDS?

VEXAS syndrome

What are the different MDS types?

What are the different MDS types?

The Importance Of Glucose Levels And Cancer Cells

The Importance Of Glucose Levels And Cancer Cells

Upcoming Events

Anemia and MDS, What You Need To Know

Anemia and MDS, What You Need To Know

Oct 03 / 15:00 EDT

HealthTree 2.0 Launch Event

HealthTree 2.0 Launch Event

Oct 23 / 17:30 MDT

Clinical Trials

articles for Clinical Trials

Promising ENHANCE Study For HR-MDS Pulled in Phase 3 Clinical Trial - Selinexor (KPT-330) For MDS The STIMULUS MDS-US Clinical Trial: Sabatolimab Added to HMA in Higher Risk MDS

HealthTree Press

articles for HealthTree Press

Announcing the Launch of HealthTree 2.0 on October 23rd Donate to HealthTree Foundation Through Your Amazon Smile Purchases HealthTree Foundation Launches New Journaling Feature for Myelodysplastic Syndromes Patients

Healthy Recipes

articles for Healthy Recipes

Healthy Recipe Idea: The Best Simple Vegan Potato Salad Strawberry Oat Bars No Bake, High Calorie Energy Bites

Thanks to our HealthTree Community for Myelodysplastic Syndromes Sponsors:

AbbVie

Bristol Myers Squibb

Follow Us

Charity Navigator

HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.

Copyright © 2023 HealthTree Foundation. All rights reserved.

Tax ID 45-5354811